-
EDITORIAL
What changes will Trump’s “Tycoon era” bring about for big pharma?
C. M. Buonamico
-
COVER STORY
Grifols
-
LATEST NEWS
Has Italy become the belly-button of Europe?
C. M. Buonamico
-
COMPANY PROFILE
OLON: the reliable partner supplier
-
A WORD WITH
Gwenael Servant – Managing Director of Les Laboratoires Servier
-
MARKET ACCESS
Supporting the patient journey – maximising patient engagement to improve outcomes
P. Rutherford, J. Procter
-
COMPANY PROFILE
Xellia Pharmaceuticals
-
BUSINESS NEWS
-
REGULATORY & COMPLIANCE
COMPLIANCE: France has approved Anti-Corruption Law Sapin II
-
INTELLECTUAL PROPERTY
The Supplementary Protection Certificates
-
MERGERS & ACQUISITIONS
Notable Life Science mergers & acquisitions in Q4 2016
E. Cruces
-
FOCUS ON DOSAGE FORM
Role of excipients in development of topical dosage forms
A. K. Goyal, G. Rath, R. Singh
-
FOCUS ON DOSAGE FORM
Why make the switch from prescription to OTC drug?
J. Lin
A dosage form perspective
-
FOCUS ON DOSAGE FORM
Who is Who in Dosage Form
-
IN & OUT
-
UPCOMING EVENTS
-
CONTRACT MANUFACTURING
Increasing role of CDMOs as partners in supporting licensing deals and New Drug Product Approvals
A. Kane
-
PRODUCT & SERVICES
-
PIPELINES
Next-generation therapies: overcoming bioprocessing, characterization and logistics challenges
C. A. Challener
-
PIPELINES
Cancer therapy reloaded
K. Perets
A review of novel treatments
-
CLINICAL PROTEOMICS
From bedside to bench: applications of proteomics for personalized medicine
P. Mauri, V. Roffia, A. De Palma, R. Rossi